These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8691618)

  • 1. [Tumor markers: neoplasmas in digestive organs].
    Takami H; Kodaira S
    Nihon Rinsho; 1996 Jun; 54(6):1616-20. PubMed ID: 8691618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers in cancer of the digestive system].
    Zinser JW
    Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biomarkers for neoplasmas in digestive organs].
    Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of serum CA 19-9 determination in digestive tract cancer].
    Chen SB
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):58-60. PubMed ID: 2364873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of serum TAC-41 in various digestive cancers].
    Sato S; Yamanaka T; Kimura K
    Rinsho Byori; 1989 Nov; 37(11):1259-62. PubMed ID: 2601083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical applications of serum tumor markers in gastroenterology].
    González Martínez M; Marín López E
    Rev Gastroenterol Mex; 1993; 58(2):103-7. PubMed ID: 7747020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
    Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system].
    Pardela M; Buntner B; Ostrowska Z; Wylezoł M; Kozłowski A; Piecuch J; Zbroński R
    Wiad Lek; 1992 Aug; 45(15-16):593-6. PubMed ID: 1283234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT; Tao HQ; Zou SC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].
    Takami H; Furuuchi T; Ogata Y; Abe O
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.